SCHEMBL31710883

SCHEMBL31710883

COC(=O)c1ccc(-c2cc3ccc(C(F)(F)F)cc3[nH]2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 4/20 0.48
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
P2RY14 Q15391 1/20 0.45
CHEK2 O96017 1/20 0.44
HDAC11 Q96DB2 2/20 0.43
CFTR P13569 1/20 0.43
KIF11 P52732 1/20 0.43
RHEB Q15382 1/20 0.42
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31710401 0.88 PTGDR2 (0.52) PTGDR2KDM4EALDH1A1CASP3SENP8
SCHEMBL21264070 0.86 P2RY14 (0.57) PTGDR2LMNAKDM4EALDH1A1HTT
SCHEMBL2721413 0.85 HPN (0.50) PTGDR2LMNAKDM4EALDH1A1HTT
SCHEMBL21248310 0.85 NOTUM (0.54) PTGDR2LMNAKDM4EALDH1A1HTT
SCHEMBL34471210 0.79 CFTR (0.49) LMNAKDM4EALDH1A1HTTL3MBTL1
SCHEMBL926647 0.79 CFTR (0.49) LMNAKDM4EALDH1A1HTTL3MBTL1
SCHEMBL28580125 0.79 RAB9A (0.61) LMNAKDM4EALDH1A1CASP3SENP8
SCHEMBL5434147 0.78 MAPT (0.57) KDM4EALDH1A1CASP3SENP8SENP7
SCHEMBL4880986 0.78 CASP3 (0.71) LMNAKDM4EALDH1A1CASP3SENP8
SCHEMBL29893090 0.77 PARP1 (0.46) LMNAKDM4EALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326777-A1 COMPOUNDS, COMPOSITIONS AND METHODS THEREOF HEPAITECH BEIJING BIOPHARMA TECH CO LTD (CN) 2025-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326777-A1 COMPOUNDS, COMPOSITIONS AND METHODS THEREOF MRGPRX4, MRGPRX1, MRGPRX2 PTGDR2 207/4885LMNA 1156/4885KDM4E 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.